The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Crystapen 600mg Powder for Solution for Injection or Infusion

Clonmel Healthcare LtdPA0126/313/001

Main Information

Trade NameCrystapen 600mg Powder for Solution for Injection or Infusion
Active SubstancesBenzylpenicillin Sodium
Dosage FormPowder for solution for injection/infusion
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/313/001

Group Information

ATC CodeJ01CE Beta-lactamase sensitive penicillins
J01CE01 benzylpenicillin


License statusAuthorised
Licence Issued20/04/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back